oral tirzepatide vs injectable semaglutide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management vs Oral Semaglutide: The – Are There Any Oral GLP-1

10.1093/biolre/ioy116 151 MengY.LyuY.GongJ.ZouY.JiangX.XiaoM.et al (2024)

Rather than outright banning compounded GLP-1 medications, expert associations can contribute to the solution by creating a seal of approval, recognizing high-quality compounded medications

"I have said throughout this process that you do not solve a quality problem by forcing the market underground." "I was encouraged by the committees recommendation because it creates an opportunity to move patients away from unverified research use only (RUO), otherwise known as grey market products, and toward a more accountable medical pathway." LaValle said his work with the International Peptide Society focuses on training clinicians about the potential benefits and risks of peptide therapies as interest in the compounds grows

So no one knows how big the market is, says Saynor